Literature DB >> 15925904

Kidney expression of RhoA, TGF-beta1, and fibronectin in human IgA nephropathy.

Letizia Mattii1, Cristina Segnani, Adamasco Cupisti, Delfo D'Alessandro, Stefania Moscato, Mario Meola, Giuliano Barsotti, Michele Marinò, Francesco Bianchi, Amelio Dolfi, Nunzia Bernardini.   

Abstract

BACKGROUND: The Rho/transforming growth factor-beta (TGF-beta) system plays a crucial role in the progression of renal damage due to stimulation of extracellular matrix molecule deposition. In fact, the in vitro TGF-beta-mediated production of fibronectin, one of the major TGF-beta-regulated extracellular components, has recently been correlated with Rho protein signalling molecules. Although a close relationship between increased renal tissue levels of TGF-beta1 and fibronectin has been reported in IgA nephropathy, no data are available on renal tissue expression of Rho proteins.
METHODS: This study was designed to assess in IgA nephropathy patients the kidney tissue immunohistochemical expression of RhoA, TGF-beta1, and fibronectin, and the rate of immunoreactivity for each antigen by image analysis.
RESULTS: An increase in RhoA, TGF-beta1, and fibronectin expression was detected in tubulointerstitium and in glomeruli of IgA nephropathy compared to normal kidneys; in particular, RhoA was found also in proximal tubules, unlike control kidneys and mainly at the cell boundary level, which is in keeping with its activated form. The image analysis confirmed that the kidney tissue levels of RhoA, TGF-beta1, and fibronectin were significantly enhanced in the patients.
CONCLUSION: This study suggests that RhoA may represent a key molecule in the signalling transduction pathway of profibrotic signals in IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925904     DOI: 10.1159/000086035

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  6 in total

1.  Fibronectin non-amyloid glomerulopathy.

Authors:  Jim L Yong; Murray C Killingsworth; S Timothy Spicer; Xiao-Juan Wu
Journal:  Int J Clin Exp Pathol       Date:  2009-11-20

2.  Mutations in FN1 cause glomerulopathy with fibronectin deposits.

Authors:  Federica Castelletti; Roberta Donadelli; Federica Banterla; Friedhelm Hildebrandt; Peter F Zipfel; Elena Bresin; Edgar Otto; Christine Skerka; Alessandra Renieri; Marta Todeschini; Jessica Caprioli; Rosa Maria Caruso; Rosangela Artuso; Giuseppe Remuzzi; Marina Noris
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

3.  Prednisone-induced sustained remission in a patient with familial fibronectin glomerulopathy (GFND).

Authors:  Bruce I Goldman; Bernard J Panner; Stephen L Welle; Matthew D Gross; Daniel A Gray
Journal:  CEN Case Rep       Date:  2021-04-10

4.  Toll-like receptor 4 signaling is involved in IgA-stimulated mesangial cell activation.

Authors:  Beom Jin Lim; Dahye Lee; Soon Won Hong; Hyeon Joo Jeong
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

5.  From expression footprints to causal pathways: contextualizing large signaling networks with CARNIVAL.

Authors:  Anika Liu; Panuwat Trairatphisan; Enio Gjerga; Athanasios Didangelos; Jonathan Barratt; Julio Saez-Rodriguez
Journal:  NPJ Syst Biol Appl       Date:  2019-11-11

6.  Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression.

Authors:  Youxia Liu; Huyan Yu; Sijing Wu; Xia Yang; Congcong Cao; Fanghao Wang; Junya Jia; Tiekun Yan
Journal:  Ther Adv Chronic Dis       Date:  2021-10-11       Impact factor: 5.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.